Even after successful cancer treatment, there is a chance that there are still dormant cancer cells in other parts of the body that previously separated from the original tumor. If awakened, these cells can proliferate and grow into metastatic tumors.

These dispersed cancer cells can remain dormant in the body for many years, in a state of hibernation, in which in addition to remaining immobile and not dividing, they remain “invisible” to the immune system.

Immune response

The reasons that cause the transition of these dispersed cells from a dormant state to an active one are not well understood yet, but it is believed that this may be due to inflammatory processes.

Neutrophils are a type of immune cell that is distinguished by finding and eliminating foreign agents in the body.
In this sense, a team of researchers at Cold Spring Harbor Laboratory discovered that inflammation can actually wake up cancer cells, and this process is triggered by one of the types of cells in our immune system: neutrophils, which are actively involved in the inflammatory response.

To test the effects of inflammation on dormant cancer cells, the researchers set up an experiment in mice. Ten individuals were injected with cells from special luminescent cancer lines.

The researchers provoked the inflammatory response in two ways: by mimicking an infection, which was achieved by spraying fragments of lipopolysaccharide (part of the bacterial cell wall) into the noses of mice, and by exposing the animals to tobacco smoke.

In the first case, it turned out that a couple of instillations of lipopolysaccharides were enough to activate neutrophils and awaken dormant cancer cells: the average intensity of the luminescence of cancer cells increased by more than a thousand times, during the month of observations.

Tobacco smoke caused a similar effect: in mice living in smoky rooms, cancer cells woke up and began to actively divide. In the control group, ten mice that were treated with harmless saline or kept in smoke-free rooms, only dormant cancer cells were detected.

The traps are responsible

Neutrophils are among the first to encounter foreign particles, whether bacteria, yeast or any other pathogen, and they have several ways of defeating their prey. One of them is to expel its DNA beyond the cell membrane and form a kind of network called the neutrophil extracellular trap.

Scattered cancer cells can remain dormant in the body for many years and then awaken and cause the disease to recur. Scientists have shown that these neutrophil traps were responsible for the awakening of cancer cells and not other inflammatory reactions.

The authors of the study observed that by preventing the formation of neutrophil traps, which they achieved using a special enzyme, the dispersed cancer cells remained inactive, causing a significant reduction in the risk of disease recurrence.

What the mouse study showed

The work focused on murine models and showed that sustained lung inflammation, caused by tobacco smoke or nasal instillation of lipopolysaccharides, could convert dormant cancer cells into aggressive lung metastases. In other words, inflammation not only accompanied the process: it functioned as a biological trigger for dormant cells to grow again.

The researchers also observed that the inflammatory response induced the formation of neutrophil extracellular traps, known as NETs. When they blocked this formation with DNase I or PAD4 inhibitors, the awakening of cancer cells was markedly reduced.

The mechanism behind awakening

The study proposed a quite specific molecular chain: two proteases associated with NETs, neutrophil elastase and MMP9, cut laminin from the extracellular matrix. That remodeled laminin activated α3β1 integrin signaling in sleeping cells and pushed their proliferation. In the experiment, antibodies against laminin remodeled by NETs prevented this awakening.

This is important because it suggests a potential way to stop the reactivation of dormant cells, but the finding remains preclinical: it was demonstrated in mice and is not equivalent to a treatment tested in people.


Discover more from TekCrispy

Subscribe to get the latest posts sent to your email.

Leave a comment

Leave a Reply